Reckitt Benckiser Group PLC

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Johann A. Benckiser in 1823 and is headquartered in Slough, the United Kingdom.

Haleon PLC

City analysts were mostly in reaction mode on Thursday as the square-mile's CFA'd scribes continued to digest what has been a busy week of trading updates and results in London's mid-cap segment. Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) was tipped as a buy, at Royal Bank of Canada, so long as management execute on its plan to ‘normalise' in the coming months – that means no more write-offs and an altogether steadier few months of trading.

Reckitt Benckiser, Flutter and Haleon under Thursday's broker spotlight

Reckitt Benckiser has had a ‘buy' view reiterated by Royal Bank of Canada (TSX:RY) analysts, who hope management's assertion that things are about normalise proves accurate. “In the absence of further one-offs, and with a chief executive announcement expected during the first half of 2023, we believe that Reckitt's undervaluation will become increasingly apparent.

Reckitt Benckiser a buy as it straightens itself out, says broker

The maker of Lysol, Clearasil and Enfamil baby formula posted solid results on Wednesday that should reassure investors it is on track.

Reckitt Cleans Up Well

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported double digit growth in operating profit and earnings per share and was in confident mood as it entered 2023. Full year revenue rose 9.2% to £14.45bn in the year to December 31, operating profit jumped 16.8% to £3.44bn and EPS advanced 18.4% to 341.7p.

Reckitt Benckiser posts double digit growth in profits, lifts dividend 5%

Reckitt Benkiser swings to higher profit in 2022, lifts its dividend payout

Britain's Reckitt Benckiser , maker of Dettol and Lysol cleaning products, on Wednesday marginally beat full-year like-for-like net revenue expectations, helped by higher prices and its nutrition and health businesses.

Reckitt beats sales estimates helped by higher prices, infant formula sales

Aston Martin Lagonda Global Holdings PLC (LSE:AML) is expected to show modest signs of recovery when it opens the bonnet on full-year results on Wednesday, according to Goldman Sachs at least. Final results are also due from blue-chip consumer goods maker Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), following some mixed numbers from rival Unilever due to continued input cost inflation.

Aston Martin's recovery and Reckitt's margins take centre stage on Wednesday

Full-year results from Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) come four months from its last update, in which time rival Unilever reported a squeeze on margins due to input cost inflation. The October update from the maker of everything from Durex condoms and Clearasil spot creams, to Air Wick fresheners and Nutramigen infant formula, revealed slower sales growth but continued confidence that it would be able to pass on all cost hikes to consumers for the rest of the year.

Is Reckitt Benckiser's margin confidence justified?

The maker of Enfamil announced a recall of about 145,000 cans of infant formula due to the possibility of cross-contamination with a bacteria that can cause serious illness or death.

Enfamil maker recalls 145k cans of potentially contaminated baby formula

Reckitt RBGPF, -3.15% , a U.K.-based consumer health and nutrition company that makes Enfamil products, is recalling 145,000 cans of baby formula over a possible bacteria contamination that could cause serious illness or even death.

Enfamil baby formula recall: 145,000 cans may have a bacteria contamination

The voluntary recall of an Enfamil ProSobee formula is over the same bacteria that played a role in last year's baby formula shortage.

Bacteria Risk Prompts Recall of 145,000 Cans of Baby Formula

Ambev

Bayer AG

Anheuser-Busch InBev

Experian PLC

Novozymes A/S

Roche Holding AG

Sanofi

Tencent Holdings Limited

Taiwan Semiconductor Manufacturing

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.

International Wide-Moat Stocks On Sale - The February 2023 Heat Map

Clorox

Manager Directed Portfolios - iM DBi Managed Futures Strategy ETF

Vanguard Extended Duration Treasury ETF

Fortis

iShares U.S. Consumer Goods ETF

Alliant Energy

Novartis

Northwest Natural Gas

Schwab US Dividend Equity ETF

TELUS

Unilever

Vanguard Health Care ETF

WEC Energy Group

The first few months of 2023 could see stocks fall 10% to 23%, and a lot of investors could make disastrous mistakes. Low-volatility high-yield blue-chips are a great way to stay invested and profit from the coming new bull market.

14 High-Yield Blue-Chips Perfect For 2023

Reckitt Benckiser owns a portfolio of well-known household brands. While Lysol and Dettol products will see a double digit revenue decrease, the 'core' portfolio should grow, thereby mitigating the impact of COVID-specific products.

Reckitt Benckiser: Not Cheap But Definitely Worth Considering

AbbVie

Abbott Labs

Alnylam Pharmaceuticals

Amgen

argenx

AstraZeneca

Baxter

BeiGene

Biogen

Bristol-Myers

United States Brent Oil Fund LP

BioNTech SE

CSL Ltd

Invesco DB Oil Fund

Daiichi Sankyo Co Ltd

Gilead Sciences

Genmab - ADR

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

iShares U.S. Oil & Gas Exploration & Production ETF

Incyte

Johnson & Johnson

Eli Lilly

Merck

Moderna

Novo Nordisk

VanEck Vectors Oil Services ETF

iPath Pure Beta Crude Oil ETN

Pfizer

Invesco Dynamic Oil & Gas Services ETF

Regeneron Pharmaceuticals

Royalty Pharma

Seagen

Takeda Pharmaceutical

ProShares Ultra Bloomberg Crude Oil

United States Oil Fund LP

Vertex Pharmaceuticals

SPDR S&P Oil & Gas Exploration & Production ETF

Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business Daily.

100 Best Stocks Of 2022: Oil Stocks And Medicals Shine

Nestle SA

Tariffs on baby formula are set to resume in the new year, despite supply chain issues and some still empty shelves.

Baby-formula imports to face tariffs again in 2023

Imported baby formula would be subject to tariffs again in the new year, after the expiration of exemptions implemented amid a nationwide shortage, the Wall Street Journal reported on Wednesday.

Baby formula imports to face tariffs again in 2023 - WSJ

Investing in UK stocks has become a lot easier for some investors over the past few months, with electronic trading introduced for London. As a result, interest for great UK companies is increasing - the reader in question asked me to take a closer look at the Reckitt Benckiser Group.

Time For Coverage Of The Reckitt Benckiser Group - It's A 'Buy'

Consumer staples makers' bonanza year of price increases coupled with falling input prices is set to come to an abrupt end in 2023 according to Credit Suisse. Input costs have fallen by 16% since April notes the broker but over that same period pricing has been ‘significant' leading to margin expansion pretty much across the board.

Reckitt Benckiser downgraded as Credit Suisse sees good times ending for consumer staples

Church & Dwight

Henkel AG & Co KGaA

Procter & Gamble

The soap and cleaning materials industry battles headwinds from elevated logistics, input and manufacturing costs. Innovation, digital growth and brand building are likely to drive players like PG, RBGLY, HENKY, CHD and CLX.

5 Soaps & Cleaning Materials Stocks Showing Potential Amid Hardships

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), owner of brands such as Cillit Bang, Dettol and Durex, is a 'buy' with household essentials likely to perform well in a recession, according to Deutsche Bank. The bank is also excited about Enfamil, Reckitt's baby formula product in the US, which “holds onto significant gains in the share of consumer interest as we move into what we expect to be a period of rising US births”.

Reckitt Benckiser a 'buy' with Deutsche Bank, likely to do well in recession

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q3 2022 Results Conference Call October 26, 2022 3:30 AM ET Company Participants Richard Joyce - Investor Relations Nicandro Durante - Chief Executive Officer Jeff Carr - Chief Financial Officer Conference Call Participants Guillaume Delmas - UBS Iain Simpson - Barclays Bruno Monteyne - Bernstein Fulvio Cazzol - Berenberg Jeremy Fialko - HSBC David Hayes - SocGen Celine Pannuti - JPMorgan Tom Sykes - Deutsche Bank Martin Deboo - Jefferies Chris Pitcher - Redburn Pinar Ergun - Morgan Stanley Karel Zoete - Kepler Cheuvreux Richard Joyce Good morning, everyone, and welcome to Reckitt's Q3 Trading Update. Jeff, our CFO, is going to take you through a brief overview of our Q3 performance, and then we will move to Q&A.

Reckitt Benckiser Group plc (RBGPF) Q3 2022 Earnings Call Transcript

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has reported a slowdown in third-quarter sales growth and said it continues to expect to pass on cost hikes to consumers for the rest of the year. Total sales for the company, which is behind brands such as Clearasil, Finish and Veet, grew by 7.4% to £3.7bn in the third quarter compared to last year.

Reckitt Benckiser reports slow down in sales; expects to continue to pass on cost hikes

Reckitt Benckiser Q3 sales rise 14% to £3.74 billion

Unilever PLC (LSE:ULVR) and Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) will both be updating the market with trading updates next week. Results elsewhere today suggest they should be coping with inflationary pressures.

News for Reckitt Benckiser Group PLC Stock (RBGLY)